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Castleman disease (CD), described as a heterogeneous lymphoproliferative disorder, can be divided into different
subtypes according to clinical appearance (unicentric and multicentric form) and histopathological features (hyaline
vascular, plasma cell, mixed type, human herpesvirus 8–associated and multicentric not otherwise specified).
Unicentric CD is known to be usually of the hyaline vascular variant, plasma cell and mixed type of this form are
quite uncommon. Malignancies are mainly associated with the multicentric form. We report a rare case of
unicentric mixed variant CD evolving into intrabronchial, extramedullary plasmacytoma.
Intrabronchial mass with consequential obstruction of the left main bronchus, left lung atelectasis and mediastinal
lymphadenomegaly was detected by chest CT in our patient suffering from cough and hemoptysis. Pulmonectomy
was performed, histopathological and immunhistochemical analysis of lymph nodes revealed mixed type of CD
with interfollicular monotypic plasma cell proliferation. The intrabronchial mass consisted of monotypic plasma cells
confirming plasmacytoma. Systemic involvement was not confirmed by further tests.
Although malignancies more often present in multicentric CD that usually belongs to the plasma cell subtype, this
case confirms the neoplastic potential of the rarest, unicentric mixed variant of CD.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/2872096831190851.
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Castleman disease (CD) - also known as giant lymph
node hyperplasia or angiofollicular lymph node hyper-
plasia - has a wide spectrum of appearances due to its
heterogeneous pathological and clinical characteristics.
It may appear in any part of the body as nodal or extra-
nodal mass.
Regarding the clinical presentation, unicentric (localized)
and multicentric (systemic) form can be identified. The
unicentric type usually presents as a benign, asymptomatic
disease affecting one single, or localized group of lymph
nodes most often observed in the mediastinal region.
Complete local surgical removal is curative in most cases.* Correspondence: noemi.eszes@gmail.com
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unless otherwise stated.Multicentric CD frequently associated with HIV infec-
tion and Kaposi’s sarcoma, is more aggressive and usually
high risk for malignant transformation into lymphoma or
other malignant lymphoproliferative diseases [1]. This
form often occurs with systemic symptoms (such as fever,
weight loss, night sweats, splenomegaly) and abnormal la-
boratory results (hypergammaglobulinemia, elevated liver
enzymes, anemia, thrombocytopenia and elevated inter-
leukin (IL)-6 levels) [2,3]. The prognosis is poor with an
overall mortality of 50%.
During the past decades, the group of CD subtypes has
been expanded. Histopathological classification has just
been modified and updated [4]. According to the new
classification, 5 forms can be distinguished: hyaline vascu-
lar, plasma cell, mixed type, human herpesvirus 8–associ-
ated and multicentric not otherwise specified CD.
The hyaline vascular type was first reported by Benjamin
Castleman in 1956 [5]. In these cases the follicle centrestd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Chest CT image of total atelectasis of the left lung.
Figure 2 2 D chest CT image of the intrabronchial mass located
3 cm from the main carina.
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that has an “onion skin” pattern due to the small lympho-
cytes that are located in concentric circles. Penetrating ves-
sels surrounded by hyalinized stroma and proliferation of
the follicular dendritic cells may also be seen. The interfolli-
cular region is highly vascularized and consists predomin-
antly of small T lymphocytes [6].
In contrast, the plasma cell variant of the disease is
characterized by follicular hyperplasia and polyclonal
interfollicular sheets of proliferating mature plasma cells
[7]. Occasionally immunoglobulin light chain (IgG or
IgA lambda) restricted plasma cell populations were also
observed [8,9].
There are casual cases described as “mixed type” in
which the histopathologic features of both variants take
place together suggesting a possible connection between
the two forms.
Two new histological categories have been described
recently: the human herpesvirus 8 (HHV-8)–associated
(plasmablastic) multicentric CD, which presents most
frequently in immunosuppressed (particularly in HIV-
positive) patients, and another subgroup, which is de-
fined as not otherwise specified multicentric CD with
non-specific pathological findings, that have similar
histologic features to that of plasma cell variant but that
cannot be classified into either HHV-8 associated or into
the plasma cell variant type [4].
Ninety percent of all cases belong to the hyaline vascu-
lar type of the disease, which is usually unicentric and
has mostly an asymptomatic course but alternatively
symptoms may occur due to localization [10]. On the
contrary the less common plasma cell and mixed vari-
ants are in most of the cases multicentric and mainly
manifest with systemic symptoms [6].
Case presentation
A nonsmoking 51-year-old obese woman presented with
cough and hemoptysis to our center for further exami-
nations. Her medical history included panic disorder,
hysterectomy due to myoma and gastroesophageal reflux
disease with concomitant Helicobacter pylori positivity
which was successfully eradicated. A few years ago she
was diagnosed with asthma but did not take the medica-
tions prescribed.
Chest X-ray showed total atelectasis of the left lung. In
addition, chest CT revealed a soft-tissue density intra-
bronchial mass located only 3 cm from the main carina
occluding the left main bronchus. Mediastinal deviation
to the left could also be seen, but no hilar or mediastinal
lymphadenopathy was observed (Figures 1 and 2). Right
lung was intact without any parenchymal abnormality.
Laboratory findings were within normal range except for
slightly elevated level of Ca2+ (2.62 mmol/L; reference
range: 2.10-2.42 mmol/L) erythrocyte sedimentation rateof 30 mm/h (reference range: 0–20 mm/h), a leukocytosis
of 20000 cells/μL (reference range: 4000–10000 cells/μL)
and slightly elevated level of uric acid of 474 μmol/L (ref-
erence range:0–340 μmol/L). Tumor markers also yielded
normal results (CEA, AFP, CA 19–9, CA 72–4, CA 15–3,
Cyfra 21–1, NSE, CA 125). Lung function test revealed
dominantly restrictive ventilatory disorder (forced vital
capacity (FVC): 2,5 L (85% predicted), forced expiratory
volume in 1 second (FEV1):1,74 L (69% predicted), FEV1/
FVC: 69%). Bronchoscopy could be performed only under
general anesthesia because of glottic spasm. During the
examination deformation of orifices with no endobron-
chial changes of the right side and - consistent with the
CT findings- complete obstruction of the left main bron-
chus could be seen (Figure 3).
Severe, massive bleeding resulted following bronchial
biopsy, so no further sampling of the lesion was possible.
Histological examination of the obtained two samples
showed groups of cells with small round nuclei in the
Figure 3 Image of virtual bronchoscopy: complete obstruction
of the left main bronchus on the left side could be seen.
Figure 4 Intrabronchial plasmacytoma consisted of atypical
plasma cells (HE magnification 100×).
Figure 5 Castleman disease with small hyalinized germinal
centers, concentric expansion of the mantle zones and
interfollicular plasma cell infiltration (HE magnification100×).
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finitive diagnosis could not be established. Abdominal
ultrasonography and mammography also were negative.
Perfusion scintigraphy showed only 8% perfusion of the
left atelectatic lung. Repeated chest CT (2 months after
the patient’s first presentation) revealed the same status
as previously detected but this time with additional me-
diastinal lymphadenopathy.
Patient underwent left side pulmonectomy with resec-
tion of the affected lymph nodes. Histological examination
showed that the intrabronchial mass was comprised of
monomorph mature plasma cells confirming endobron-
chial plasmacytoma. In peribronchial lymph nodes de-
pleted germinal centres were revealed with expanded
mantle zone showing the “onion skin” pattern due to the
concentric layers of small lymphocytes. Interfollicular area
consisted mainly of lymphocytes and interfollicular vascu-
larisation. In other areas interfollicular sheets of mature
plasma cells were shown with similar morphology as that
of the plasma cells in the intrabronchial mass (Figures 4
and 5). Immunohistochemistry demonstrated the plasma
cells to be positive for CD 31 with immunoglobulin
lambda light chain restriction (Figures 6 and 7). These
findings were consistent with the mixed variant of CD as-
sociated with endobronchial plasmocytoma. Systemic in-
volvement was not confirmed by further hematological
tests. Bone marrow aspiration showed no clonal plasma
cell populations, biopsy could not be performed because
of the patient’s obesity. Although serum protein electro-
phoresis with immunofixation showed the presence of
monoclonal lambda light chain protein, it decreased rap-
idly after surgery. Urine test for Bence Jones protein was
negative. A metastatic bone survey was performedincluding imaging X-rays of the skull, vertebral column,
pelvis, and extremities. A lesion suspicious for metastasis
of the right proximal femur was detected, therefore PET-
CT scan was performed, but it did not confirm activity.
Tree years after surgery the patient is asymptomatic,
with no signs of recurrence of the disease.
Discussion
CD is usually reported as a rare benign disorder character-
ized by lymphocyte proliferation but several case reports
published in the last decades proved its malignant poten-
tial. Malignancies are usually present with the multricentric
form of CD including Kaposi sarcoma, B cell lymphoma,
Hodgkin’s lymphoma and plasmacytoma. Other conditions
were also observed accompanying mainly the multricentric
form, e.g. POEMS syndrome (polyneuropathy, organome-
galy, endocrinopathy, monoclonal gammopathy, and skin
changes), nephrotic syndrome, amyloidosis, connective tis-
sue diseases and other autoimmune disorders [11,12]. In
the hyaline vascular type of CD, dendritic cell tumors and
vascular neoplasms have been described most frequently.
Figure 6 Monotypical lambda light chain restricted cells in
plasmacytoma (magnification 400×).
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centric CD, may be associated with a special entity named
“large B-cell lymphoma arising in HHV-8-associated multi-
centric CD” or “HHV-8-positive plasmablastic lymphoma”
consisting of IgM lambda expressing immunoblasts that
are located in the mantle zone. Interestingly, somatic
hypermutation of immunoglobulin genes did not occur in
this type of lymphoma [13].
Unicentric cases of CD followed by lymphoma or soli-
tary plasmacytoma are quite spare and were reported only
in a few cases [14]. Extramedullary plasmacytoma present-
ing simultaneously with the unicentric variant is even more
uncommon, an intracranial form with hyaline-vascular type
of CD was described previously [15]. Extramedullary
plasmacytoma is an extremely rare entity of its own,
takes up approximately 4% of all plasma cell tumors
[16]. The lymphoid cells in CD of all pathologic types
are mainly polyclonal. In some cases, lymph node extra-
medullary plasmacytoma arising in Castleman diseaseFigure 7 Mixed variant of Castleman disease with lambda
monoclonal plasma cell infiltration (magnification 400×).was diagnosed based on the presence of monotypic IgG
or IgA λ plasma cell infiltration [17-20]. Of note, in patients
suffering from CD with monotypic plasma cell infiltrates,
cytogenetic analysis -detected by immonhistochemistry-
does not always show any immunoglobulin gene rearrange-
ments in the background [21,22]. The difference between
plasma cell type CD with monoclonal plasma cells and
lymph node plasmacytoma is not clear, it is still a question
whether plasma cell variant CD with monoclonal plasma
cells can be diagnosed as plasmacytoma. Diagnosis of
plasma cell type CD with monoclonal plasma cells was
recommended when some CD specific follicles can also be
seen. Lack of these pathological characteristics substanti-
ates the diagnosis of plasmacytoma [23].
The etiology of CD is not fully elucidated. The role of
IL-6 cytokine may be one of the key components in the
pathophysiology of the disease, its overexpression in ger-
minal center cells of the lymph nodes was shown in the
plasma cell type of CD [24]. In mice IL-6 induced histo-
logical and clinical changes were specific to CD [25]. IL-6
is responsible among others for acute phase response,
CD4 T cell differentiation, B cell growth and differenti-
ation into plasma cells. Its role was suggested in the devel-
opment of B cell lymphomas and plasmacytomagenesis,
thus it may be a link between plasmacytoma and plasma
cell type of CD [26]. IL-6 also increases the production of
hepcidin, which was described to be associated with iron
deficiency anaemia in mixed type of CD [27]. Further-
more, IL-6 stimulates the expression of vascular epithelial
growth factor (VEGF), causing vascular proliferation,
which is thought to be of great importance in the develop-
ment of vascular neoplasms in CD. In HHV8 associated
CD, the virus encodes a viral homologue of IL-6, that in-
duces the expression of VEGF [28] which may stimulate
the human IL-6 production. This mechanism may partici-
pate in the development of the HHV8 associated multi-
centric CD. Recently, epidermal growth factor receptor
(EGFR) overexpression was observed in both CD and fol-
licular dendritic cell (FDC) sarcoma, thus EGFR was sug-
gested to be a connection between hyaline vascular CD
and FDC sarcoma [29].
The definitive diagnosis of CD is based on histology.
The results should be carefully evaluated as other lym-
phoproliferative disorders, especially lymphomas with
plasmablastic features may resemble to CD regarding
the histopathologic features. Plasmablastic lymphomas
are also often associated with HIV or HHV8 infections
similar to multicentric CD, and even EBV (Epstein-Barr
virus) may occur in both entity [30,31]. Low-grade
mucosa-associated lymphoid tissue (MALT) lymphomas
also need to be distinguished from plasma cell type of
CD. B cells are known to be characterized by CD5 ex-
pression in the expanded mantle zones of CD. In con-
trast, CD5 positivity is unusual in MALT lymphomas
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mimic CD [33]. For establishing the accurate diagnosis,
careful histopathologic examinations are needed, immuno-
histological examinations and immunologic gene rearrange-
ment analysis can be helpful in the differentiation.
The optimal treatment for patients with unicentric
disease is surgical excision, which is usually curative irre-
spectively of the histological variant. If the disease is non-
resecable, additional treatments - adjuvant steroid therapy
and radiotherapy - were reported to be successful [34].
Therapeutic options for patients with multricentric dis-
ease are more variable including corticosteroids (given
temporarily according to the degree of the symptoms),
combination chemotherapy regimens, intravenous im-
munoglobulin, antiviral medications, anti–IL-6 therapy
and even bone marrow transplantation.
In cases of EMP, radiotherapy was accepted in general
to be the first-line treatment based on the radiosensitiv-
ity of the disease. Small lesions may be cured with sur-
gery without radiotherapy. Radiotherapy should be only
considered when residual local disease can be detected.
In our case surgical excision was part of the diagnosis.
In respect of our patient, there is no evidence of benefit
of adjuvant radiotherapy. Surgery was curative, the pa-
tient has no recurrence of the disease after 3 years of
follow-up.
Conclusion
Unicentric CD with concomitant neoplasm is a rare con-
dition. Plasma cell or mixed type CD with monoclonal
proliferation is even more exceptional. We reported a
unique association of unicentric, mixed type CD with
monoclonal plasma cell infiltration associated with
extramedullary, intrabronchial plasmacytoma proving
the neoplastic potential of this entity. According to pre-
vious findings plasma cell malignancy may have devel-
oped due to the elevated IL-6 levels, although we have
not measured it in our patient. The significance of
monoclonality present in plasma cell or mixed type of
CD is still not clear; however according to our case, sur-
gical removal of the lesions might be curative. Further
studies are warranted to analyze the clinicopathological
and cytogenetic characteristics of this condition and fol-
low up more cases.
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